TLR2 and influenza: An example of such an application is modelling the effect of treatments that modulate the innate immune response, such as the toll-like receptor-2 agonist Pam2Cys which has been shown to stimulate innate immune signals and reduce influenza-associated mortality and morbidity in animal studies [27].